Phage diabody repertoires for selection of large numbers of bispecific antibody fragments

Nature Biotechnology
B T McGuinnessH R Hoogenboom

Abstract

Methods for the generation of large numbers of different bispecific antibodies are presented. Cloning strategies are detailed to create repertoires of bispecific diabody molecules with variability on one or both of the antigen binding sites. This diabody format, when combined with the power of phage display technology, allows the generation and analysis of thousands of different bispecific molecules. Selection for binding presumably also selects for more stable diabodies. Phage diabody libraries enable screening or selection of the best combination bispecific molecule with regards to affinity of binding, epitope recognition and pairing before manufacture of the best candidate.

References

Dec 5, 1991·Journal of Molecular Biology·J D MarksG Winter
Aug 15, 1991·Nature·T ClacksonG Winter
Jan 24, 1991·Nature·G Winter, C Milstein
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J S HustonR Crea
Nov 1, 1987·British Journal of Cancer·K D Bagshawe
Oct 6, 1983·Nature·C Milstein, A C Cuello
Jul 18, 1995·Proceedings of the National Academy of Sciences of the United States of America·M MackP Kufer
Dec 15, 1994·Structure·O PerisicR L Williams
Aug 1, 1993·Current Opinion in Biotechnology·P Holliger, G Winter
Jan 1, 1994·Annual Review of Immunology·G WinterH R Hoogenboom
Jul 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·P HolligerG Winter

❮ Previous
Next ❯

Citations

Feb 27, 2001·Journal of Immunological Methods·A TodorovskaP J Hudson
Jan 23, 1999·Journal of Immunological Methods·J A ChappelA S Kang
Jan 29, 2000·Journal of Immunological Methods·P J Hudson, A A Kortt
Aug 1, 2000·Immunology Today·H R Hoogenboom, P Chames
Jun 6, 2000·Advanced Drug Delivery Reviews·H R Hoogenboom de Haard H
Apr 1, 1997·Current Opinion in Immunology·M S HaydenJ A Ledbetter
Sep 27, 2002·Current Opinion in Biotechnology·Helen Petach, Larry Gold
Aug 1, 1997·Current Opinion in Biotechnology·P Carter, A M Merchant
Aug 1, 1997·Current Opinion in Biotechnology·C Rader, C F Barbas
Mar 21, 1998·Current Opinion in Biotechnology·A D Griffiths, A R Duncan
Jun 1, 1997·Immunotechnology : an International Journal of Immunological Engineering·A Plückthun, P Pack
Jul 14, 1998·Immunotechnology : an International Journal of Immunological Engineering·H R HoogenboomR C Roovers
Sep 22, 2001·Biomolecular Engineering·A A KorttP J Hudson
Apr 1, 1997·Immunology and Cell Biology·Y Iba, Y Kurosawa
Feb 1, 1997·Nature Biotechnology·H R Hoogenboom
Jul 1, 1997·Nature Biotechnology·R E KontermannG Winter
Jul 1, 1997·Nature Biotechnology·P HolligerG Winter
Sep 10, 2005·Nature Biotechnology·Hennie R Hoogenboom
Nov 17, 2012·Nature Protocols·Aftabul Haque, Nicholas K Tonks
Oct 17, 1998·British Journal of Pharmacology·M RouschH R Hoogenboom
Feb 5, 2003·Advanced Drug Delivery Reviews·Ying Cao, Laura Lam
May 1, 2008·Expert Review of Clinical Immunology·Shyam Mohapatra, Homero San Juan
May 5, 2007·Expert Opinion on Biological Therapy·Itai Benhar
Sep 29, 2005·Expert Opinion on Biological Therapy·Jean-Luc Teillaud
Aug 27, 2005·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·W J J FinlayJ E Slater
Jul 21, 2004·Journal of Immunological Methods·Andrew R M Bradbury, James D Marks
Jul 31, 2016·Biochemical and Biophysical Research Communications·Masanao NakayamaNobuhide Doi
Apr 27, 2017·Protein Engineering, Design & Selection : PEDS·Séverine FagèteOliver Hartley
Apr 16, 1998·International Journal of Cancer. Journal International Du Cancer·W HelfrichL de Leij
Jan 29, 2021·Viruses·Kazuya Nagano, Yasuo Tsutsumi
Sep 2, 2011·Cold Spring Harbor Protocols·Jennifer Andris-WidhopfCarlos F Barbas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Engineering

Antibody engineering technologies are constantly advancing to improve the clinical effectiveness of monoclonal and bispecific antibodies. Discover the latest research on Antibody Engineering here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.